The Role of Nurses in Video-Based Communication to Reduce Loneliness in Intensive Care Unit Patients (VBC-ICU)

July 8, 2025 updated by: Universitas Padjadjaran

The Effect of Video-Based Communication on Reducing Loneliness in Intensive Care Unit Patients: A Quasi-Experimental Study

This study aims to evaluate the effectiveness of video-based communication in reducing loneliness among intensive care unit (ICU) patients at Dr. Hasan Sadikin General Hospital in Bandung, Indonesia. ICU patients often experience psychological distress, particularly loneliness, due to restricted family visits and physical isolation.

A quasi-experimental design with a pre-test and post-test control group is used, involving 36 participants who are randomly assigned to either the intervention or control group. The intervention group receives structured video-based communication with family members for three consecutive days, with each session lasting between 5 to 20 minutes. Nurses facilitate the intervention by ensuring patient safety, providing emotional support, and assisting with the communication process. The control group receives standard ICU care without the communication intervention.

Loneliness levels are assessed using the De Jong Gierveld Loneliness Scale (DJGLS) before and after the intervention.

Study Overview

Status

Completed

Detailed Description

This study investigates the effectiveness of video-based communication in reducing loneliness among patients in the Intensive Care Unit (ICU). Loneliness is a common psychosocial issue in ICU patients, caused by physical isolation, limited visitation policies, and minimal social interaction. It is associated with increased stress, potential suppression of immune response, and extended hospitalization. The intervention provides a practical approach by enabling virtual interaction with family members, allowing emotional connection despite physical distance.

The study uses a quasi-experimental design with a pre-test and post-test control group. A total of 36 patients are recruited from Dr. Hasan Sadikin General Hospital in Bandung and randomly assigned to either an intervention or control group. The intervention group receives structured video-based communication using WhatsApp for three consecutive days, with each session lasting between 5 and 20 minutes. The control group receives standard ICU care without the additional communication support. The De Jong Gierveld Loneliness Scale (DJGLS) is used to assess emotional and social loneliness levels before and after the intervention.

Nurses act as primary facilitators in the intervention. Their responsibilities include ensuring clinical stability, setting up the communication devices, emotionally supporting patients during the sessions, monitoring patient responses, documenting the process, and coordinating communication with family members.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jawa Barat
      • Bandung, Jawa Barat, Indonesia, 40161
        • dr. Hasan Sadikin General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients admitted to the intensive care unit (ICU)
  2. Patients aged over 18 years with a minimum of 72 hours of care in the ICU
  3. Patients who are able to understand and communicate in the Indonesian language

Exclusion Criteria:

  1. Patients with medical conditions such as decreased consciousness, total blindness, or severe neurological disorders
  2. Patients with a history of psychiatric disorders

Drop Out:

  1. Patients who are discharged from the ICU of Dr. Hasan Sadikin General Hospital during the study period will be considered drop-outs
  2. Patients whose health deteriorates to the extent that they are unable to continue participation in the study
  3. Patients who die during the study period
  4. Patients who are transferred from the ICU to general inpatient wards

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group - Video-based Communication
Participants in this group received structured video-based communication with their family members using WhatsApp. Each session lasted 5-20 minutes and was conducted once daily for three consecutive days. The communication was facilitated by a nurse and included positive messages, emotional support, and discussion of future plans. The aim was to reduce emotional and social loneliness in ICU patients.
Participants received structured video-based communication sessions with their family members using the WhatsApp platform. The intervention was delivered once daily for three consecutive days, with each session lasting between 5 and 20 minutes. Communication was guided to include emotional support, positive conversations, and future-oriented discussion. The sessions were facilitated by nurses who ensured clinical stability, technical setup, and emotional readiness of the patient. This intervention aimed to reduce emotional and social loneliness among ICU patients and was integrated into standard intensive care routines without disrupting medical care.
No Intervention: Control Group - Standard ICU Care
Participants in this group received standard ICU care without any video-based communication intervention. They continued with routine treatment and monitoring in the ICU setting for the duration of the study period. This group was used as a comparison to assess the impact of video-based communication on loneliness levels.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Loneliness Score (De Jong Gierveld Loneliness Scale)
Time Frame: Baseline (Day 1) to Post-Intervention (Day 3)
This outcome measures the change in loneliness among ICU patients before and after the intervention, using the De Jong Gierveld Loneliness Scale (DJGLS). The scale assesses both emotional and social loneliness with 11 items, validated in Indonesian. Higher scores indicate greater loneliness. The score is recorded at baseline (pre-intervention) and after 3 days of intervention (post-test). The difference in mean scores is used to assess effectiveness.
Baseline (Day 1) to Post-Intervention (Day 3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cecep Eli Kosasih, S.Kp., MNS., Ph.D, Universitas Padjadjaran
  • Study Director: Ristina Mirwanti, S.Kep., Ners., M.Kep., Universitas Padjadjaran

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 24, 2024

Primary Completion (Actual)

January 24, 2025

Study Completion (Actual)

January 24, 2025

Study Registration Dates

First Submitted

June 29, 2025

First Submitted That Met QC Criteria

July 8, 2025

First Posted (Actual)

July 18, 2025

Study Record Updates

Last Update Posted (Actual)

July 18, 2025

Last Update Submitted That Met QC Criteria

July 8, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • NURS-202506.01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Loneliness

Clinical Trials on Video-based Communication

Subscribe